Treatment Options for UTI Caused by Morganella morganii and Enterococcus faecalis
Based on the susceptibility testing results, ciprofloxacin is the most effective treatment option for this polymicrobial urinary tract infection caused by Morganella morganii and Enterococcus faecalis.
Analysis of Susceptibility Results
The urine culture shows two organisms with >100,000 CFU/mL each:
The only antibiotics effective against both organisms are:
Treatment Recommendation Algorithm
First-line Treatment
Alternative Treatment
Special Considerations for Morganella morganii
- M. morganii is an opportunistic pathogen that can cause serious infections with high mortality rates if not properly treated 2, 5
- This organism is often resistant to multiple antibiotics including:
- M. morganii frequently produces AmpC β-lactamases, which can develop resistance during treatment with certain β-lactams 2, 6
Special Considerations for Enterococcus faecalis
- E. faecalis is intrinsically resistant to many antibiotics including trimethoprim-sulfamethoxazole (despite this isolate testing susceptible) 1
- For vancomycin-resistant enterococci (not the case here), linezolid or tigecycline would be appropriate 1
- The isolate is resistant to tetracycline, which is a common finding for enterococci 1
Treatment Duration
- For complicated UTIs (polymicrobial infections are generally considered complicated), treatment duration should be 7-14 days 1
- A shorter course (7 days) may be considered when the patient has been afebrile for at least 48 hours and is hemodynamically stable 1
- Longer duration (14 days) is recommended if there are concerns about prostatitis in male patients 1
Common Pitfalls to Avoid
- Do not use nitrofurantoin despite E. faecalis being susceptible, as M. morganii is resistant and nitrofurantoin doesn't achieve adequate tissue concentrations for upper UTIs 7, 2
- Do not use trimethoprim-sulfamethoxazole despite susceptibility results for M. morganii, as enterococci are often clinically resistant despite in vitro susceptibility 1, 8
- Do not use amoxicillin/clavulanic acid as M. morganii is resistant 2, 6
- Monitor for resistance development during therapy, especially with M. morganii which can develop resistance through AmpC β-lactamase production 2, 5